Medics2You vs Relaymed: Revenue, Funding & Team Size Compared
Medics2You generates $2.9M in revenue; Relaymed generates $3M. Relaymed and Medics2You are close to the same size by revenue. The table below compares Medics2You and Relaymed on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  Medics2YouThis company |  Relaymed |
|---|---|---|
| Revenue | $2.9M | $3M |
| Valuation | $1.1M | $23.6M |
| Funding raised | $196.1K | Not disclosed |
| Team size | 49 | 26 |
| Founded | 2018 | 2012 |
| HQ | London, United Kingdom | Edinburgh, United Kingdom |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Medics2You at a glance
Medics2You generates $2.9M in revenue with 49 employees, headquartered in London, United Kingdom.
- Revenue
- $2.9M
- Valuation
- $1.1M
- Funding
- $196.1K
- Team size
- 49
- Founded
- 2018
A Health-Tech SaaS Provider in Africa
Relaymed at a glance
Relaymed generates $3M in revenue with 26 employees, headquartered in Edinburgh, United Kingdom.
- Revenue
- $3M
- Valuation
- $23.6M
- Team size
- 26
- Founded
- 2012
Developer of a healthcare software. The company develops a software that connects point-of-care devices in the physician practice with the electronic health record.
Other Medics2You alternatives
Medics2You competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Medics2You vs Relaymed: frequently asked questions
Is Medics2You or Relaymed bigger?
Relaymed is the bigger company by revenue, at $3M against $2.9M for Medics2You.
How much revenue does Medics2You make?
Medics2You generates $2.9M in annual revenue with a team of 49.
How much revenue does Relaymed make?
Relaymed generates $3M in annual revenue with a team of 26.
How much funding has Medics2You raised?
Medics2You has raised $196.1K in total funding since it was founded in 2018.